NCT06820723View on ClinicalTrials.gov

A Mechanistic Study to Assess a Single Dose of CYB003 in Participants With Depression and Anxiety

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

November 30, 2027

Conditions
DepressionAnxietyMajor Depressive Disorder
Interventions
DRUG

CYB003

synthetic, deuterated isotopomer of psilocin

DRUG

Placebo

Placebo orange drink solution

Trial Locations (1)

43210

The Ohio State University Department of Psychiatry, Columbus

All Listed Sponsors
lead

Ohio State University

OTHER